PERSPECTA

News from every angle

← Back to headlines

AstraZeneca's $400 Billion Deal Unravels Amid Investor Revolt

A potential $400 billion deal involving AstraZeneca reportedly fell apart after a significant number of investors expressed strong opposition.

12 Aug, 04:00 — 12 Aug, 04:00
PostShare

Sources

Showing 1 of 1 sources
FTVery High6d ago

How AstraZeneca’s $400bn deal unravelled

A chorus of investors revolted against the potential agreement

Read full article →

Related Stories

German Farmers Face Significant Harvest Losses Due to Drought

27m ago

Klarna Stock Plunges 20% Following Trimmed Guidance

32m ago

Home Depot Exceeds Q2 Earnings Estimates Amidst Stagnant Housing Market

41m ago

Mark Walter Reportedly Selling Off Sports Holdings After Lakers Deal

52m ago